Valuation : Vista Pharmaceuticals Limited

Market Cap 376M 3.98M 3.43M 3.24M 2.95M 5.51M 5.55M 38.3M 14.87M 192M 14.95M 14.62M 632M P/E 2024
-10.3x
P/E 2025 -13.6x
Enterprise Value 443M 4.69M 4.04M 3.81M 3.47M 6.49M 6.54M 45.1M 17.5M 226M 17.6M 17.22M 744M EV / Sales 2024
7.63x
EV / Sales 2025 8.85x
Free-Float
22.51%
Yield 2024 *
-
Yield 2025 -
1 day+2.46%
1 week+3.65%
Current month-0.48%
1 month-5.02%
3 months-21.01%
6 months+4.00%
Current year-23.34%
1 week 5.8
Extreme 5.8
6.49
1 month 5.8
Extreme 5.8
7.28
Current year 5.71
Extreme 5.71
8.87
1 year 5.71
Extreme 5.71
10.75
3 years 5.71
Extreme 5.71
19.7
5 years 5.71
Extreme 5.71
19.7
10 years 4.51
Extreme 4.51
56.15
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Compliance Officer - 09/02/2024
Director TitleAgeSince
Chairman 76 01/01/2014
Director/Board Member 87 15/06/1993
Director/Board Member 76 01/02/2010
Change 5-day change 1-year change 3-year change Capi.($)
+2.46%+3.65%-38.58%-58.15% 3.97M
-0.81%+0.14%+21.37%+72.78% 49.06B
+0.41%+0.49%+52.69%+119.28% 40.37B
-0.97%-3.88%+13.37%+84.21% 12.19B
-1.28%-1.78%-11.64%+12.58% 12.08B
+0.57%+0.95%+29.02%+153.11% 9.14B
0.00%-4.19%+23.91%+43.34% 7.36B
-0.04%-0.04%+22.68%+222.92% 7.35B
+0.81%+1.38%+44.31%-10.54% 7.32B
-1.29%-1.78%-40.82%+14.36% 5.19B
Average -0.01%-0.20%+11.63%+65.39% 15.01B
Weighted average by Cap. -0.31%+0.35%+26.11%+86.09%

Financials

2024 2025
Net sales 103M 1.09M 940K 885K 806K 1.51M 1.52M 10.48M 4.07M 52.6M 4.09M 4M 173M 101M 1.07M 920K 867K 790K 1.48M 1.49M 10.26M 3.98M 51.51M 4M 3.92M 169M
Net income -45.12M -478K -412K -388K -354K -661K -666K -4.6M -1.78M -23.07M -1.79M -1.75M -75.78M -46.49M -492K -425K -400K -364K -681K -686K -4.73M -1.84M -23.77M -1.85M -1.81M -78.07M
Net Debt 78.7M 833K 719K 677K 617K 1.15M 1.16M 8.02M 3.11M 40.24M 3.13M 3.06M 132M 66.71M 706K 609K 574K 523K 977K 985K 6.79M 2.64M 34.11M 2.65M 2.59M 112M
Logo Vista Pharmaceuticals Limited
Vista Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing of pharmaceutical products. The Company offers over the counter and prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. The Company has its United States Food and Drug Administration (USFDA) approved manufacturing facility in India and its marketing and distribution center in United States. Its products include tablet dosage forms and capsule dosage forms. The Company's tablet dosage forms in United States market include sulfamethoxazole & trimethoprim (400/80 mg) and acetaminophen (500 mg) film coated. The Company's tablet dosage forms in Non-United States market include aspirin (300, 325 & 500 mg), atenolol (50 & 100 mg), cotrimoxazole (480 mg), captopril (25 & 50 mg) and frusemide (40 mg). Its capsule dosage forms in Non-United States market include indomethacin (25 mg), piroxicam (10 & 20 mg) and nifedipine (10 mg).
Employees
30
Date Price Change Volume
03/09/26 6.240 +2.46% 2,240
02/09/26 ₹6.090 +1.50% 4,905
01/09/26 ₹6.000 -4.31% 5,939
31/08/26 ₹6.270 -1.10% 9,143
28/08/26 ₹6.340 +5.32% 8,559
  1. Stock Market
  2. Stocks
  3. VISTAPH6 Stock